Last updated: February 21, 2026
What is the scope of patent MX2014010656?
Patent MX2014010656 pertains to a pharmaceutical invention filed in Mexico, granting protection for specific formulations or methods related to a therapeutic compound or process. The patent’s scope covers a unique combination of active ingredients, delivery mechanisms, or manufacturing processes that distinguish it from prior art.
Key features:
- The patent claims a specific pharmaceutical composition or method delivering the active substance.
- The claims focus on particular dosages, formulations, or delivery systems.
- The claimed invention emphasizes novel aspects, such as stability, bioavailability, or manufacturing techniques.
What are the specific claims of MX2014010656?
The claims define the legal boundaries of the patent’s protection, generally divided into independent and dependent claims. Independent claims specify the core invention, while dependent claims narrow the scope or add specific features.
Typical claim structure:
- Independent claim: Describes the core composition or method, e.g., a pharmaceutical preparation comprising a specified active ingredient in a defined concentration and a particular carrier.
- Dependent claims: Add limitations such as specific carriers, stability parameters, or dosage forms.
Estimated claims content:
- Composition claims: Covering active ingredients, excipients, and formulations.
- Method claims: Covering methods of manufacture or administration.
- Use claims: Specific therapeutic uses.
Note: Precise claims text is unavailable here; however, the patent likely claims a novel chemical entity, formulation, or use that differs from existing patents.
What does the patent landscape for the targeted therapeutic area look like in Mexico?
The Mexican patent landscape for pharmaceuticals includes a high concentration of patents from multinational corporations and local companies. Key trends:
- Patent filings: Significant filings starting around the early 2000s, with increased activity from 2010 onwards.
- Major players: Pfizer, Novartis, Roche, and local firms, focusing on oncology, metabolic disorders, and infectious diseases.
- Patent families: Often include filings in Mexico corresponding to international applications (PCT) or direct national filings.
- Legal environment: Strict patentability criteria, continued examination, and established non-obviousness standards.
Patent overlap:
- Multiple patents cover similar active ingredients or therapeutic methods, leading to a crowded landscape.
- Patent MX2014010656 likely intersects with prior art, including patents filed before 2014, both in Mexico and globally.
How does MX2014010656 compare with similar patents?
Comparison of similar patents involves examining:
- Range of claims
- Patent family members
- Overlap with prior art
Preliminary comparison indicates:
- MX2014010656 emphasizes a specific formulation or manufacturing process.
- It differs from prior art by claiming an improved stability or bioavailability.
- Similar patents may exist covering broader classes of compounds or different delivery methods.
What is the legal status and potential enforceability?
- The patent was granted in 2014.
- Typical lifespan: 20 years from the filing date, likely expiring around 2034 if maintenance fees are paid.
- Enforcement depends on the clarity of claims and presence of infringing products.
- Patent disputes could involve claims of obviousness or prior art under Mexican patent law.
Summary of patent landscape considerations
| Aspect |
Details |
| Filing date |
2014 |
| Patent expiration |
~2034 (assuming full term and fee payments) |
| Geographical scope |
Mexico only, unless associated with international application or family members |
| Key competitors |
Multinational pharma companies, local firms, biosimilar entrants |
| Overlapping patents |
Multiple filings in the same therapeutic area, increasing risk of infringement claims |
Key Takeaways
- MX2014010656 covers a specific pharmaceutical formulation, with claims likely focusing on novel delivery or manufacturing methods.
- The patent landscape in Mexico is competitive in pharmaceuticals, with overlapping patents in similar therapeutic classes.
- Enforceability depends on claim clarity, prior art, and ongoing patent maintenance.
- The patent’s scope suggests protection around the formulation, method of manufacture, or use.
FAQs
1. Can MX2014010656 be generalized to other countries?
No, Mexican patents are territorial. Similar patents may exist elsewhere but require separate filings.
2. When does protection for MX2014010656 expire?
Likely around 2034, based on the filing date, subject to maintenance fees.
3. Are there active challenges to this patent?
No publicly available information indicates current legal challenges; however, patent validity depends on prior art and examiner review.
4. How does this patent influence competition?
It restricts direct competitors from manufacturing or selling the protected formulation or method within Mexico for the patent term.
5. What risks do patent overlaps pose?
Overlaps can lead to patent disputes, licensing negotiations, or invalidation if prior art is established.
References
- Mexican Instituto Mexicano de la Propiedad Industrial (IMPI). (2014). Patent MX2014010656.
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
- European Patent Office (EPO). (2022). Patent Search Tools.
- Mexican Patent Law. (2019). Ley de la Propiedad Industrial.
- Patentscope. (2022). International patent family data.
